• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生活方式管理治疗肥胖症。

The therapeutics of lifestyle management on obesity.

机构信息

University of Oxford, OCDEM, Churchill Hospital, Oxford, Oxfordshire, UK.

出版信息

Diabetes Obes Metab. 2010 Nov;12(11):941-6. doi: 10.1111/j.1463-1326.2010.01256.x.

DOI:10.1111/j.1463-1326.2010.01256.x
PMID:20880340
Abstract

The global incidence and prevalence of obesity continue to increase, with the fastest rate of increase in the developing world. Obesity is associated with many chronic diseases including type 2 diabetes, cardiovascular disease and some cancers. Weight loss can reduce the risk of developing these diseases and can be achieved by means of surgery, pharmacotherapy and lifestyle interventions. Lifestyle interventions for prevention and treatment of obesity include diet, exercise and psychological interventions. All lifestyle interventions have a modest but significant effect on weight loss, but there is little evidence to indicate that any one intervention is more effective. There is evidence of an additive effect for adjunct therapy, and the combination of diet, exercise and behavioural interventions appears to be most effective for both the prevention and treatment of obesity.

摘要

全球肥胖的发病率和患病率持续上升,发展中国家的增长速度最快。肥胖与许多慢性疾病有关,包括 2 型糖尿病、心血管疾病和某些癌症。减肥可以降低这些疾病的发病风险,可以通过手术、药物治疗和生活方式干预来实现。预防和治疗肥胖的生活方式干预包括饮食、运动和心理干预。所有生活方式干预对减肥都有适度但显著的效果,但几乎没有证据表明任何一种干预更有效。辅助治疗有累加效应,饮食、运动和行为干预的联合似乎对肥胖的预防和治疗最有效。

相似文献

1
The therapeutics of lifestyle management on obesity.生活方式管理治疗肥胖症。
Diabetes Obes Metab. 2010 Nov;12(11):941-6. doi: 10.1111/j.1463-1326.2010.01256.x.
2
Treatment modalities of obesity: what fits whom?肥胖的治疗方式:哪种适合谁?
Diabetes Care. 2008 Feb;31 Suppl 2:S269-77. doi: 10.2337/dc08-s265.
3
Management of Obesity.肥胖管理。
J Clin Oncol. 2016 Dec 10;34(35):4295-4305. doi: 10.1200/JCO.2016.66.8806. Epub 2016 Nov 7.
4
Medical management of obesity.肥胖的医学管理。
Acta Clin Belg. 2006 Sep-Oct;61(5):286-94. doi: 10.1179/acb.2006.048.
5
Weight management in people with type 2 diabetes.2型糖尿病患者的体重管理
Br J Community Nurs. 2007 Sep;12(9):390-7. doi: 10.12968/bjcn.2007.12.9.27232.
6
The role of lifestyle interventions and weight management in schizophrenia.生活方式干预和体重管理在精神分裂症中的作用。
J Psychopharmacol. 2005 Nov;19(6 Suppl):28-35. doi: 10.1177/0269881105058682.
7
Weight Loss Strategies for Treatment of Obesity: Lifestyle Management and Pharmacotherapy.肥胖治疗的体重减轻策略:生活方式管理和药物治疗。
Prog Cardiovasc Dis. 2018 Jul-Aug;61(2):246-252. doi: 10.1016/j.pcad.2018.06.001. Epub 2018 Jun 8.
8
Current management strategies in the treatment of obesity.肥胖治疗中的当前管理策略。
Nurs Stand. 2010;25(14):49-56; quiz 58, 60. doi: 10.7748/ns2010.12.25.14.49.c8155.
9
Combining behavioral and pharmacological treatments for obesity.结合行为疗法和药物疗法治疗肥胖症。
Obes Res. 2002 Jun;10(6):560-74. doi: 10.1038/oby.2002.77.
10
Behavior therapy for obesity: where are we now?肥胖症的行为疗法:我们目前处于什么阶段?
Curr Opin Endocrinol Diabetes Obes. 2009 Oct;16(5):347-52. doi: 10.1097/MED.0b013e32832f5a79.

引用本文的文献

1
Rising mortality rates linked to type-2 diabetes and obesity in the United States: An observational analysis from 1999 to 2022.美国2型糖尿病和肥胖相关死亡率上升:1999年至2022年的一项观察性分析。
J Diabetes Investig. 2025 Mar;16(3):492-500. doi: 10.1111/jdi.14386. Epub 2024 Dec 19.
2
Sexual Dimorphism's impact on adipogenesis: A three-dimensional in vitro model treated with 17β-estradiol and testosterone.性二态性对脂肪生成的影响:用 17β-雌二醇和睾酮处理的三维体外模型。
Mol Cell Endocrinol. 2024 Aug 1;589:112249. doi: 10.1016/j.mce.2024.112249. Epub 2024 Apr 9.
3
ATP releasing channels and the ameliorative effects of high intensity interval training on diabetic heart: a multifaceted analysis.
三磷酸腺苷释放通道与高强度间歇训练对糖尿病心脏的改善作用:多方面分析。
Sci Rep. 2024 Mar 26;14(1):7113. doi: 10.1038/s41598-024-57818-0.
4
The Role of Obesity in Type 2 Diabetes Mellitus-An Overview.肥胖在 2 型糖尿病中的作用——概述。
Int J Mol Sci. 2024 Feb 4;25(3):1882. doi: 10.3390/ijms25031882.
5
Artesunate treats obesity in male mice and non-human primates through GDF15/GFRAL signalling axis.青蒿琥酯通过 GDF15/GFRAL 信号轴治疗雄性小鼠和非人灵长类动物的肥胖。
Nat Commun. 2024 Feb 3;15(1):1034. doi: 10.1038/s41467-024-45452-3.
6
Efficacy and Tolerability of Semaglutide in Patients With Type-2 Diabetes Mellitus: Experience of a Tertiary Care Hospital, Pakistan.司美格鲁肽在2型糖尿病患者中的疗效和耐受性:巴基斯坦一家三级护理医院的经验
Clin Med Insights Endocrinol Diabetes. 2023 Nov 24;16:11795514231213568. doi: 10.1177/11795514231213568. eCollection 2023.
7
Association of the Clínica Universidad de Navarra-Body Adiposity Estimator With Type 2 Diabetes: A Retrospective Cohort Study.《纳瓦拉大学临床医学院体脂估算器与 2 型糖尿病的相关性:一项回顾性队列研究》。
Int J Public Health. 2023 Sep 21;68:1606063. doi: 10.3389/ijph.2023.1606063. eCollection 2023.
8
Assessment of common risk factors of diabetes and chronic kidney disease: a Mendelian randomization study.评估糖尿病和慢性肾脏病的常见危险因素:一项孟德尔随机研究。
Front Endocrinol (Lausanne). 2023 Sep 13;14:1265719. doi: 10.3389/fendo.2023.1265719. eCollection 2023.
9
Comparison of Plasma Exosome Proteomes Between Obese and Non-Obese Patients with Type 2 Diabetes Mellitus.肥胖与非肥胖2型糖尿病患者血浆外泌体蛋白质组的比较
Diabetes Metab Syndr Obes. 2023 Mar 7;16:629-642. doi: 10.2147/DMSO.S396239. eCollection 2023.
10
Effects of combination of obesity, diabetes, and hypoxia on inflammatory regulating genes and cytokines in rat pancreatic tissues and serum.肥胖、糖尿病和缺氧对大鼠胰腺组织和血清中炎症调节基因和细胞因子的影响。
PeerJ. 2022 Oct 4;10:e13990. doi: 10.7717/peerj.13990. eCollection 2022.